The Scientific Research Team at Tyra Biosciences is dedicated to investigating novel pathways of acquired resistance in oncology. This team leverages its expertise to develop purpose-built drugs, conducting rigorous preclinical and clinical research to ensure efficacy and safety for patient treatment.